Search hospitals > Iowa > Boone
McFarland Clinic PC-Boone
Claim this profileBoone, Iowa 50036
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Adenocarcinoma
184 reported clinical trials
2 medical researchers
Summary
McFarland Clinic PC-Boone is a medical facility located in Boone, Iowa. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. McFarland Clinic PC-Boone is involved with conducting 184 clinical trials across 365 conditions. There are 2 research doctors associated with this hospital, such as Debra M. Prow and Joseph J. Merchant.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Debra M. ProwMcFarland Clinic PC - Ames4 years of reported clinical research
Expert in Cancer
Expert in Lung Cancer
125 reported clinical trials
185 drugs studied
Joseph J. MerchantMcFarland Clinic - Ames4 years of reported clinical research
Expert in Cancer
Expert in Lung Cancer
88 reported clinical trials
141 drugs studied
Clinical Trials running at McFarland Clinic PC-Boone
Breast Cancer
Melanoma
Lung Cancer
Cancer
Bladder Cancer
Non-Small Cell Lung Cancer
Renal Cell Carcinoma
Bladder Carcinoma
Cutaneous Melanoma
Squamous Cell Carcinoma
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Sacituzumab Govitecan
for Brain Metastases from Breast Cancer
This phase II trial studies the effect of sacituzumab govitecan in treating patients with HER2-negative breast cancer that has spread to the brain (brain metastases). Sacituzumab govitecan is a monoclonal antibody, called sacituzumab, linked to a chemotherapy drug, called govitecan. Sacituzumab is a form of targeted therapy because it attaches to specific molecules on the surface of cancer cells, known as Trop-2 receptors, and delivers govitecan to kill them. Giving sacituzumab govitecan may shrink the cancer in the brain and/or extend the time until the cancer gets worse.
Recruiting1 award Phase 212 criteria
Chemotherapy Reduction After Surgery
for Breast Cancer
This trial studies how well paclitaxel, trastuzumab, and pertuzumab work in eliminating further chemotherapy after surgery in patients with HER2-positive stage II-IIIa breast cancer who have no cancer remaining at surgery (either in the breast or underarm lymph nodes) after pre-operative chemotherapy and HER2-targeted therapy. Drugs used in chemotherapy, such as paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Trastuzumab and pertuzumab are both a form of "targeted therapy" because they work by attaching themselves to specific molecules (receptors) on the surface of tumor cells, known as HER2 receptors. When these drugs attach to HER2 receptors, the signals that tell the cells to grow are blocked and the tumor cell may be marked for destruction by the body's immune system. Giving paclitaxel, trastuzumab, and pertuzumab may enable fewer chemotherapy drugs to be given without compromising patient outcomes compared to the usual treatment.
Recruiting1 award Phase 227 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at McFarland Clinic PC-Boone?
McFarland Clinic PC-Boone is a medical facility located in Boone, Iowa. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. McFarland Clinic PC-Boone is involved with conducting 184 clinical trials across 365 conditions. There are 2 research doctors associated with this hospital, such as Debra M. Prow and Joseph J. Merchant.